US › Healthcare

Carlsmed, Inc. Common Stock (CARL)

US · Healthcare · Health Information Services

$13.43+3.87%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$16.1M
Revenue YoY
+58.2%
Net profit
$-8.7M
Profit YoY
-51.8%
EPS
$-0.26
EPS estimate
$-0.39
Net margin
-54.0%

EPS came in at -0.26 against a street estimate of -0.39 — a beat of 33.3%.

Key statistics

Market cap
$342.3M
Forward P/E
0.0
P/B
3.70
Book value
$3.39
EPS (TTM)
$-0.97
52-week high
$17.19
52-week low
$8.50
50-day MA
$11.41
200-day MA
$11.89

Analyst view

with an average price target of $18.60.

Shareholding

Insiders
43.73%
Institutions
40.36%

Largest institutional holders

FundStake
Orbimed Advisors, LLC4.61%
HHG PLC4.52%
Parkman Healthcare Partners LLC1.92%
BlackRock Inc1.64%
Schonfeld Strategic Advisors LLC1.04%
Vanguard Capital Management, LLC1.02%
KCM Capital Inc0.74%
Geode Capital Management, LLC0.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Carlsmed, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.